Allarity Therapeutics | Investor Conference Presentation Deck

Allarity Therapeutics | Investor Conference Presentation Deck | 23 slides

Allarity Therapeutics · 2022-09

arc beats above · slides in the middle · loops below · scroll → 2 LOOPS

Deck intelligence map

coverage by narrative range · generated from this deck JSON

Narrative range 25 total

Metadata

Components

Metrics

Tools

Frameworks

Beats

Loops

Problem 5 slides 100% 5/5 slides 100% 5/5 slides · 27 hits

— 0/5 slides

40% 2/5 slides 40% 2/5 slides 100% 5/5 slides · 6 hits 100% 5/5 slides · 6 hits Agitate 6 slides 100% 6/6 slides 100% 6/6 slides · 30 hits

— 0/6 slides

83.3% 5/6 slides 66.7% 4/6 slides 100% 6/6 slides · 8 hits 100% 6/6 slides · 7 hits Solution 14 slides 100% 14/14 slides 100% 14/14 slides · 81 hits

— 0/14 slides

42.9% 6/14 slides 42.9% 6/14 slides 100% 14/14 slides · 15 hits 7.1% 1/14 slides

Slide inventory

every slide · same image gating as the playbook

front_matter

Open slide detailBeat · ProblemLoop · Cost Of Inaction

other

Open slide detailBeat · ProblemLoop · Cost Of Inaction

summarize

Open slide detailBeat · ProblemLoop · Cost Of Inaction

The slide uses a standard pharmaceutical pipeline grid format.present_solution

Open slide detailBeat · ProblemLoop · Cost Of Inaction

Uses a before-after framing to contrast traditional 'one-size-fits-all' medicine with personalized medicine.present_solution

Open slide detailBeat · ProblemLoop · Before After

The slide uses a network graph to illustrate complexity and a funnel/filter diagram to illustrate the DRP engine process.present_framework

Open slide detailBeat · AgitateLoop · Before After

The slide uses a process flow to explain the diagnostic mechanism.present_framework

Open slide detailBeat · AgitateLoop · Before After

The slide highlights clinical validation across 47 trials, split between prospective Phase 2 and retrospective Phase 2/3 studies.analyze_data

Open slide detailBeat · AgitateLoop · Before After

Includes clinical trial references and a stacked bar chart comparing 2019A vs 2026E market size.quantify_opportunity

Open slide detailBeat · AgitateLoop · Before After

The slide demonstrates the predictive power of the DRP biomarker by contrasting the entire study population (no benefit) with the DRP-selected subgroup (signifianalyze_data

Open slide detailBeat · AgitateLoop · Before After

Includes a stacked bar chart showing market growth projections for ovarian and pancreatic cancer.quantify_opportunity

Open slide detailBeat · Solution

Mentions DRP (Drug Response Predictor) as a companion diagnostic to justify pricing premium.propose_solution

Open slide detailBeat · Solution

Includes a stacked bar chart showing market growth from 2019A to 2026E.quantify_opportunity

Open slide detailBeat · Solution

The slide uses a box plot to show the distribution of DRP scores between clinical responders and non-responders, with a clear cutoff at 50.analyze_data

Open slide detailBeat · Solution

The table uses checkmarks and X marks to highlight the competitive advantage of Stenoparib.compare_peers

Open slide detailBeat · Solution

Includes clinical efficacy data (PFS) and commercial context.establish_context

Open slide detailBeat · Solution

The slide uses a dot plot to show biomarker sensitivity distribution and a bar chart to compare ORR outcomes.present_solution

Open slide detailBeat · Solution

The slide uses a timeline framework to visualize clinical trial phases and interim data milestones.plan_implementation

Open slide detailBeat · Solution

other

Open slide detailBeat · Solution

introduce_nominees

Open slide detailBeat · Solution

introduce_nominees

Open slide detailBeat · Solution

The slide uses a timeline-like structure to organize milestones by drug program.plan_implementation

Open slide detailBeat · Solution

front_matter

Open slide detailBeat · Solution